________________________________________________________________________________ monitored with Calypso (Varian) for gating and tracking treatments, and compensated with the PerfectPitch couch (Varian) for tracking. The dose in the moving tumor was measured with Gafchromic EBT2 (ISP) films. Changes in homogeneity indices (ΔH1-99) between the films and the planned dose distributions and their gamma agreement scores using 3%/3mm (GS3%/3mm) were evaluated. The film areas receiving more than the planned minimum dose (A>Dmin) were calculated. OAR doses from the treatment plans were compared.
Material and Methods:
The tracking accuracy of a 4D ultrasound system (Clarity Anticosti, Elekta, Sweden) was evaluated using an ultrasound phantom (BAT, Nomos) and a motion platform (CIRS, USA) with different settings to obtain optimal parameters to track structures moving with respiration. An initial evaluation was performed with 5 healthy volunteers to assess the performance in a quasiclinical setting. An ultrasound dataset was acquired in ABCbased breath hold (breath hold time 20 sec, free breathing phases of 5-6 breathing cycles). Tracked structures were renal pelvis as a centroid structure and a portal vein/liver vein as a non-centroid structure. The scanning range of the ultrasound probe was varied. The motion component in superior-inferior direction was compared with the motion of an external marker on the body surface and the data from ABC.
Results: a) Phantom data: The tracking accuracy increased with decreasing scanning range. For a cycle time (sinusoidal motion) of 10 s and an amplitude of 10 mm, the mean and standard deviation of differences between the measured and the reference position values were 0.57 + 0.48 mm and 0.31 + 0.20 mm in 15° and 5° scanning range respectively,while for a cycle time of 5 s were 1.33 + 1.20 mm and 0.34 + 0.25 mm for 8° and 4° scanning range respectively. For a fixed scanning range, the accuracy of ultrasound tracking decreased with a decrease of cycle times. b) Volunteer data: The system's tracking success rate was 90.77% of all breath-hold phases.The renal pelvis tracking success rate was 95.42%, while 86.79% for portal vein.A compromise between scanning range and cycle times had to be established depending on target. A working scanning range was between 10°-40°. For angles <10°there is a higher risk that the target is sometimes outside the ultrasound. This will lead to a reduced tracking success rate. Tracking curves (SI direction)were in good accordance with breathing curves of ABC and a fiducial placed on the infradiaphragmatic abdominal wall.
Conclusion:
The ultrasound system showed good performance on a motion phantom and healthy volunteers. A positioning setup that provides good ultrasound visual over a long period in clinical environment could be established. Further improvement of the tracking algorithm could improve accuracy along with respiratory motion if using large scanning angles for detection of high-amplitude motion and non-linear transformations of the tracking target. Purpose or Objective: The emergence of hypofractionated protocols in prostate cancer treatment requires a better accuracy in dose delivery because of an increased risk of toxicity to the safe tissues. The aim of this study was to evaluate intrafraction motions of the target volumes for prostate cancer patients imaged with a new transperineal ultrasound (TP-US) device.
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Material and Methods:
The accuracy of the tracking of the TP-US (Clarity®, Elekta, Stockholm, Sweden) probe was first investigated by comparing the measured positions of a target volume in a phantom with the Clarity device and the simultaneous use of a transmitter based positioning device (RayPilot, Micropos Medical, Sweden). Then intra-fraction motions measured with the TP-US were analyzed for 13 prostate patients (426 sessions) and 14 post-prostatectomy patients (438 sessions). The fraction of time that the target volume was displaced by more than 3 and 5 mm was calculated for tracking times ranging between 60-420s, for each session and each patient. The mean displacements were also calculated for each direction. Percentages of sessions for which thresholds of 3 mm and 5 mm were exceeded during 15 s and 30 s in each direction were determined.
Results:
Differences between TP-US and transmitter based devices were below 1.5 mm for all directions. The observed motions were patients and sessions dependent and increased with the treatment time. During the first minute, 3D displacements above 3 mm were seen 5% and 1.9% of the time, for prostate and post-prostatectomy patients, respectively while they reached 38% and 10.8% of the time after 7 min of treatment. Maximum 3D displacements above 5 mm were observed after 7 min 11.6% and 1.6% of the time for prostate and post-prostatectomy patients, respectively. Mean displacements in AP, SI and LR directions were -0.9±0.8mm, 0.9±0.8mm and -0.3±0.5mm for prostate patients and -0.9±0.5mm, 0.2±0.4mm and 0.1±0.4mm for postprostatectomy patients. The maximum percentage of sessions for which the prostate and post-prostatectomy volumes exceeded the 3 mm tracking limits for at least 15 s was observed in the AP direction (Table 1) . Conversely, minimum S820 ESTRO 35 2016 _____________________________________________________________________________________________________ displacements were observed in the lateral direction for prostate patients (4.5%), and in the SI direction for postprostatectomy patients (0.7%). Table 1 :
Conclusion:
Results for prostate patients are in agreement with the previously published data [1] . 4D TP-US modality is a promising alternative to irradiating and/or invasive IGRT modalities for intrafraction prostate motion management. In contrast, smaller displacements were observed for postprostatectomy patients than those reported in the literature [2] . Further investigations are in progress to determine the causes of these discrepancies. Purpose or Objective: To design a moving phantom capable oftime-resolved 2D dosimetry with the goal of validating gated radiotherapytreatments. A preliminary study was carried out to validate the arrangement withgated-exposures using the Varian real-time position management™ (RPM) system, installedon four different Truebeam® linacs (operating v.1.5, 1.6 and 2.0).
Material and Methods:
The phantom consists of a PTW OCTAVIUS® 1000 SRSarray combined with a programmable moving platform and is capable of measuring2D dose profiles with a 100 ms acquisition rate. In this preliminary study thearray oscillated sinusoidally (2.5 cm amplitude) with 3 different breathingperiods (3, 4 and 6 s) while irradiated with a 6 MV, 4 × 4 cm 2 field. Amplitude gating was employed to activate four Truebeams when the arraywas within ±20% and ±30% of the central position and at the 20% extremes of itsmotion. Additional time-resolved information on the activation of the linac wasacquired via oscilloscope traces of the targetBNC output, and analysis of corresponding trajectory log files. All datasources were analysed using MATLAB 7.10, where GUIs were developed to interpretthe variation in position of the 2D dose profiles and to compare thetime-resolved data contained within the four data sources.
Results: Fig. 1 shows results obtained via each of theacquisition methods during a gated exposure. A phase correction term isincluded in the OCTAVIUS, log file and target signal data ( Fig. 1 (a), (b) and(c) respectively), so that the first two segments agreed with the RPM data. Inthis example, the agreement is not maintained throughout the entire exposure.Both the OCTAVIUS and target signal data ( Fig. 1 (d) and (f) respectively) aredelayed with respect to the RPM trace data and flags. Table. 1, this anomaly was observed on Truebeam versions 1.5 and1.6 but not on version 2.0. The opposite trend was observed in the log filecomparison ( Fig. 1  (e) ), where the beam-on flags lead the RPM beamenableflags. For all irradiations it was observed that log file beam-on flags ledthe corresponding target beam-onsignal and that the time delay between the two signals was proportional to thenumber of segments.
Asindicated in
Conclusion:
Preliminarytests with the new phantom have indicated that the RPM system can accurately enablethe linac output when the phantom position is within set gating parameters.However, using this novel arrangement, it was discovered that a discrepancy occasionallyoccurred on RPM systems installed on Truebeam versions 1.5 and 1.6. For someexposures a difference of up to 0.4 s was observed between data recorded by theRPM system and data extracted from the OCTAVIUS and target signal. The phantomalso highlighted a consistent discrepancy in the time information recorded inthe log files, where the cycle period of each exposure segment wasunderestimated by 10 ms, leading to differences of up to 0.6 s between the logfile and "true" target signal data.
